Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS)

CNY 40.96

(2.24%)

Inventory Summary of Shanghai Yizhong Pharmaceutical Co., Ltd.

  • Shanghai Yizhong Pharmaceutical Co., Ltd.'s latest annual inventory in 2023 was 28.4 Million CNY , up 66.5% from previous year.
  • Shanghai Yizhong Pharmaceutical Co., Ltd.'s latest quarterly inventory in 2024 Q2 was 30.51 Million CNY , up 0.88% from previous quarter.
  • Shanghai Yizhong Pharmaceutical Co., Ltd. reported annual inventory of 17.06 Million CNY in 2022, up 44.81% from previous year.
  • Shanghai Yizhong Pharmaceutical Co., Ltd. reported annual inventory of 11.78 Million CNY in 2021, up 697.74% from previous year.
  • Shanghai Yizhong Pharmaceutical Co., Ltd. reported quarterly inventory of 30.51 Million CNY for 2024 Q2, up 0.88% from previous quarter.
  • Shanghai Yizhong Pharmaceutical Co., Ltd. reported quarterly inventory of 30.18 Million CNY for 2024 Q3, down -1.08% from previous quarter.

Annual Inventory Chart of Shanghai Yizhong Pharmaceutical Co., Ltd. (2023 - 2017)

Historical Annual Inventory of Shanghai Yizhong Pharmaceutical Co., Ltd. (2023 - 2017)

Year Inventory Inventory Growth
2023 28.4 Million CNY 66.5%
2022 17.06 Million CNY 44.81%
2021 11.78 Million CNY 697.74%
2020 1.47 Million CNY -45.9%
2019 2.73 Million CNY 19.45%
2018 2.28 Million CNY 705.4%
2017 283.76 Thousand CNY 0.0%

Peer Inventory Comparison of Shanghai Yizhong Pharmaceutical Co., Ltd.

Name Inventory Inventory Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 490.07 Million CNY 94.204%
Yabao Pharmaceutical Group Co., Ltd 442.13 Million CNY 93.575%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 11.5 Billion CNY 99.753%
Harbin Pharmaceutical Group Co., Ltd. 1.92 Billion CNY 98.524%
Tasly Pharmaceutical Group Co., Ltd 1.74 Billion CNY 98.375%
Zhejiang Medicine Co., Ltd. 2.01 Billion CNY 98.587%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 1.56 Billion CNY 98.187%
Lionco Pharmaceutical Group Co.,Ltd. 56.76 Million CNY 49.962%
Humanwell Healthcare (Group) Co.,Ltd. 3.61 Billion CNY 99.215%
Ginwa Enterprise (Group) Inc. 26.24 Million CNY -8.224%
Joincare Pharmaceutical Group Industry Co.,Ltd. 2.65 Billion CNY 98.93%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 84.32 Million CNY 66.313%
China Animal Husbandry Industry Co., Ltd. 1.09 Billion CNY 97.404%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 29.51 Million CNY 3.751%
Zhejiang Huahai Pharmaceutical Co., Ltd. 3.43 Billion CNY 99.172%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.14 Billion CNY 97.52%
Ningbo Menovo Pharmaceutical Co., Ltd. 612.59 Million CNY 95.363%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.95 Billion CNY 98.55%
Chongqing Taiji Industry(Group) Co.,Ltd 2.69 Billion CNY 98.944%
HPGC Renmintongtai Pharmaceutical Corporation 1.11 Billion CNY 97.453%
Nanjing Well Pharmaceutical Group Co.,Ltd. 170.57 Million CNY 83.347%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 725.58 Million CNY 96.085%
Henan Lingrui Pharmaceutical Co., Ltd. 467.35 Million CNY 93.922%
Shenzhen Chipscreen Biosciences Co., Ltd. 47.12 Million CNY 39.728%
Guizhou Yibai Pharmaceutical Co., Ltd. 586.65 Million CNY 95.158%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 350.1 Million CNY 91.887%
Zhongzhu Healthcare Holding Co.,Ltd 545.25 Million CNY 94.79%
Beijing Tongrentang Co., Ltd 9.34 Billion CNY 99.696%
KPC Pharmaceuticals, Inc. 1.68 Billion CNY 98.317%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 43.65 Million CNY 34.926%
North China Pharmaceutical Company Ltd. 2.6 Billion CNY 98.911%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 1.56 Billion CNY 98.182%
Tibet Weixinkang Medicine Co., Ltd. 38.34 Million CNY 25.92%
China National Medicines Corporation Ltd. 3.96 Billion CNY 99.283%
Zhejiang Hisun Pharmaceutical Co., Ltd. 1.95 Billion CNY 98.548%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 720.88 Million CNY 96.06%
ChengDu ShengNuo Biotec Co.,Ltd. 194.32 Million CNY 85.383%
Dali Pharmaceuticalco.,Ltd 63.84 Million CNY 55.506%
Changchun BCHT Biotechnology Co. 199.01 Million CNY 85.727%
Zhejiang Shengda Bio-Pharm Co., Ltd. 228.48 Million CNY 87.568%
Shanghai Jiaoda Onlly Co.,Ltd 40.73 Million CNY 30.259%
Jiang Zhong Pharmaceutical Co.,Ltd 406.16 Million CNY 93.006%
Mayinglong Pharmaceutical Group Co., LTD. 273.47 Million CNY 89.613%
Cisen Pharmaceutical Co., Ltd. 708.21 Million CNY 95.989%
Hunan Warrant Pharmaceutical Co.,Ltd 362.66 Million CNY 92.168%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 7.53 Billion CNY 99.623%
Jianmin Pharmaceutical Group Co.,Ltd. 450.84 Million CNY 93.699%
Hunan Fangsheng Pharmaceutical Co., Ltd. 328.28 Million CNY 91.347%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 776.12 Million CNY 96.34%
Guobang Pharma Ltd. 1.36 Billion CNY 97.924%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 199.34 Million CNY 85.751%
Kangmei Pharmaceutical Co., Ltd. 2.64 Billion CNY 98.926%
Shandong Buchang Pharmaceuticals Co., Ltd. 4.93 Billion CNY 99.424%
Zhejiang Starry Pharmaceutical Co.,Ltd. 1.14 Billion CNY 97.526%
Henan Taloph Pharmaceutical Stock Co.,Ltd 455.49 Million CNY 93.764%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 534.13 Million CNY 94.682%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 4.15 Billion CNY 99.317%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 14.4 Million CNY -97.136%
Shanghai Shyndec Pharmaceutical Co., Ltd. 2.28 Billion CNY 98.754%
Tibet Rhodiola Pharmaceutical Holding Co. 111.43 Million CNY 74.509%
Sichuan Huiyu Pharmaceutical Co., Ltd. 153.11 Million CNY 81.448%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 116.78 Million CNY 75.676%
CanSino Biologics Inc. 387.45 Million CNY 92.669%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 315.44 Million CNY 90.995%
Shandong Lukang Pharmaceutical Co.,Ltd. 1.4 Billion CNY 97.98%